Development of CYP2J2 gene therapy for glomeruonephritis and diabetic nephropathy
CYP2J2基因治疗肾小球肾炎和糖尿病肾病的进展
基本信息
- 批准号:17590832
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
CYP2J2 is a crucial regulator of epoxyeicosatrienoic acid production from arachidonic acid. Epoxyeicosatrienoic acid is a vasodilator that relaxes vascular smooth muscle cells and has anti-inflammatory properties against vascular cells. Therefore, it is indicated that induction of CYP2J2 gene in mesangial cells and endothelial cells shows protective effects against kidney by the improvement of blood flow and anti-inflammatory effects.We studied the effects of angiotensin II, that promotes oxidative stress and inflammation in vascular cells, on CYP2J2 gene expression. We demonstrated increased CYP2J2 mRNA expression in cultured endothelial cells and mesangial cells by RT-PCR. Tumor necrosis factor-a that is an inflammatory cytokine showed similar effects on CYP2J2 mRNA expression in cultured endothelial cells and mesangial cells. These data suggest that inflammatory stimuli increase CYP2J2 mRNA expression in endothelial cells and mesangial cells.Also, we demonstrated that tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression is decreased by overexpression of CYP2J2 in cultured endothelial cells. This result indicates that CYP2J2 overexpression in endoithelial cells has anti-inflammatory effects.
CYP2J2 是花生四烯酸生产环氧二十碳三烯酸的重要调节因子。环氧二十碳三烯酸是一种血管扩张剂,可以放松血管平滑肌细胞,并对血管细胞具有抗炎特性。因此,表明系膜细胞和内皮细胞中CYP2J2基因的诱导通过改善血流和抗炎作用显示出对肾脏的保护作用。我们研究了促进血管细胞氧化应激和炎症的血管紧张素II对CYP2J2基因表达的影响。我们通过 RT-PCR 证明了培养的内皮细胞和系膜细胞中 CYP2J2 mRNA 表达增加。肿瘤坏死因子-a 是一种炎症细胞因子,对培养的内皮细胞和系膜细胞中的 CYP2J2 mRNA 表达显示出类似的影响。这些数据表明,炎症刺激增加了内皮细胞和系膜细胞中CYP2J2 mRNA的表达。此外,我们还证明,培养的内皮细胞中CYP2J2的过表达会降低肿瘤坏死因子-α诱导的细胞间粘附分子-1的表达。该结果表明CYP2J2在内皮细胞中过表达具有抗炎作用。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
糖尿病患者における心血管合併症の予防と治療 食後高血糖による血管内皮機能の障害とその制御
糖尿病患者心血管并发症的防治、餐后高血糖引起的血管内皮功能损伤及其控制
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Nagase M;et al.;野出孝一
- 通讯作者:野出孝一
Partial blood recirculation : A new trial for prolonging filter life during continuous hemodiafiltration.
部分血液再循环:一项延长连续血液透析滤过期间过滤器寿命的新试验。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Ikeda Y;Kishi T;Kishi C;Miyazono M;Ohtsubo S;Nakashima M;Sakemi T;Ando T;Node K
- 通讯作者:Node K
外因性NO供与の臨床的意義・血管弛緩因子のNOとEETの関係
外源性NO供应的临床意义/血管舒张剂NO与EET的关系
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Usui HK;Shikata K;Sasaki M;Okada S;Matsuda M;Shikata Y;Ogawa D;Kido Y;Nagase R;Yozai K;Ohga S;Tone A;Wada J;Takeya M;Horiuchi S;Kodama T;Makino H.;野出孝一
- 通讯作者:野出孝一
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYAZONO Motoaki其他文献
MIYAZONO Motoaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
- 批准号:
24K19287 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
- 批准号:
494564 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
- 批准号:
495437 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
- 批准号:
23K06224 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
- 批准号:
23K08020 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
- 批准号:
10740433 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
- 批准号:
23K10101 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
- 批准号:
23K10809 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
- 批准号:
10738361 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:














{{item.name}}会员




